144 related articles for article (PubMed ID: 1301584)
21. When should we stop intravesical treatment in patients with superficial bladder cancer?
von Heyden B; Jakse G
Recent Results Cancer Res; 1993; 126():127-33. PubMed ID: 8456183
[No Abstract] [Full Text] [Related]
22. Instillation therapy in superficial urinary bladder cancer. Finnbladder Group.
Jauhiainen KE; Alfthan OS
Scand J Urol Nephrol Suppl; 1991; 138():179-85. PubMed ID: 1785001
[TBL] [Abstract][Full Text] [Related]
23. Editorial comment on: Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder cancer.
Evans CP
Eur Urol; 2007 Oct; 52(4):1129-30. PubMed ID: 17383082
[No Abstract] [Full Text] [Related]
24. Introduction and overview of intravesical therapy for superficial bladder cancer.
Soloway MS
Urology; 1988 Mar; 31(3 Suppl):5-16. PubMed ID: 3126593
[TBL] [Abstract][Full Text] [Related]
25. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
[TBL] [Abstract][Full Text] [Related]
26. Intravesical adjuvant treatment in superficial bladder cancer. A review of the question after 15 years of experience with the EORTC GU group.
Bouffioux C
Scand J Urol Nephrol Suppl; 1991; 138():167-77. PubMed ID: 1838428
[No Abstract] [Full Text] [Related]
27. [Postoperative and adjuvant intravesical therapy of superficial bladder tumours. Clinical practice and applied therapeutic agents].
Lingnau A; Miller K; Steiner U; Jentzmik F; Weikert S; Schostak M
Aktuelle Urol; 2009 Sep; 40(5):307-9. PubMed ID: 19637135
[TBL] [Abstract][Full Text] [Related]
28. Integral photodynamic therapy of superficial bladder tumors with special reference to carcinoma in situ.
Hisazumi H; Naito K; Uchibayashi T; Hirata A; Komatsu K
Scand J Urol Nephrol Suppl; 1991; 138():161-5. PubMed ID: 1785000
[TBL] [Abstract][Full Text] [Related]
29. Intravesical chemotherapy for superficial bladder tumors category Ta/T1: who should be treated and how?
Kurth KH
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):30-5. PubMed ID: 8727808
[TBL] [Abstract][Full Text] [Related]
30. Transurethral resection and intravesical therapy of superficial bladder tumors.
Herr HW
Urol Clin North Am; 1991 Aug; 18(3):525-8. PubMed ID: 1877115
[TBL] [Abstract][Full Text] [Related]
31. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
[TBL] [Abstract][Full Text] [Related]
32. Intravesical therapy: does it affect the natural history of superficial bladder cancer?
Lamm DL; Griffith JG
Semin Urol; 1992 Feb; 10(1):39-44. PubMed ID: 1565903
[No Abstract] [Full Text] [Related]
33. Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors.
Colombo R; Da Pozzo LF; Lev A; Salonia A; Rigatti P; Leib Z; Servadio C; Caldarera E; Pavone-Macaluso M
J Urol; 1998 Mar; 159(3):783-7. PubMed ID: 9474148
[TBL] [Abstract][Full Text] [Related]
34. Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma.
Ord JJ; Streeter E; Jones A; Le Monnier K; Cranston D; Crew J; Joel SP; Rogers MA; Banks RE; Roberts IS; Harris AL
Br J Cancer; 2005 Jun; 92(12):2140-7. PubMed ID: 15928663
[TBL] [Abstract][Full Text] [Related]
35. Intravesical instillation of bacille Calmette-Guérin for superficial bladder cancer: cost-effectiveness analysis.
Uchida A; Yonou H; Hayashi E; Iha K; Oda M; Miyazato M; Oshiro Y; Hokama S; Sugaya K; Ogawa Y
Urology; 2007 Feb; 69(2):275-9. PubMed ID: 17320663
[TBL] [Abstract][Full Text] [Related]
36. Apparent failure of current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladder.
Lamm DL; Riggs DR; Traynelis CL; Nseyo UO
J Urol; 1995 May; 153(5):1444-50. PubMed ID: 7714962
[TBL] [Abstract][Full Text] [Related]
37. [Indications for topical therapy in superficial bladder cancer].
Krege S
Urologe A; 1992 Jul; 31(4):201-2. PubMed ID: 1514197
[No Abstract] [Full Text] [Related]
38. Intravesical interferon alfa in the treatment of superficial bladder cancer.
Williams RD
Semin Oncol; 1988 Oct; 15(5 Suppl 5):10-3. PubMed ID: 3057641
[No Abstract] [Full Text] [Related]
39. Electromotive drug administration with mitomycin C for intravesical treatment of non-muscle invasive transitional cell carcinoma.
Kalsi J; Harland SJ; Feneley MR
Expert Opin Drug Deliv; 2008 Jan; 5(1):137-45. PubMed ID: 18095933
[TBL] [Abstract][Full Text] [Related]
40. Surgical management of superficial bladder cancer (stages Ta/T1/CIS).
Smith JA
Semin Surg Oncol; 1997; 13(5):328-34. PubMed ID: 9259088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
